Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1/2 5Phase NA 3Phase 3 3Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 27Lymphoma 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Lymphoma, Non-Hodgkin 21Leukemia 21Multiple Myeloma 18Leukemia, Myeloid, Acute 18Lymphoma, Large B-Cell, Diffuse 17Hodgkin Disease 16Myelodysplastic Syndromes 15Lymphoma, Mantle-Cell 15Lymphoma, Follicular 15Leukemia, Lymphocytic, Chronic, B-Cell 14Congenital Abnormalities 12Lymphoma, B-Cell, Marginal Zone 11Burkitt Lymphoma 11Primary Myelofibrosis 10Myeloproliferative Disorders 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, T-Cell, Cutaneous 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Myeloid, Accelerated Phase 9Neoplasms, Plasma Cell 8Dendritic Cell Sarcoma, Interdigitating 8Blast Crisis 8Recurrence 7Sezary Syndrome 6Myelodysplastic-Myeloproliferative Diseases 6Mycosis Fungoides 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6

Interventions

Magnetic Resonance Spectroscopy 4Therapeutics 3Immunoenzyme Techniques 3Early Intervention, Educational 3Cyclophosphamide 3Biopsy 3saponin QA-21V1 2exemestane 2Vorinostat 2Standard of Care 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2Letrozole 2Immunologic Techniques 2Gene Expression Profiling 2Fluorodeoxyglucose F18 2Flow Cytometry 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Bevacizumab 2Anastrozole 2Acupuncture Therapy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2pegfilgrastim 1iso-sulfan blue 1alovudine 1Zoledronic Acid 1Trastuzumab 1Tomography, Emission-Computed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms, Male × Cyclophosphamide × Clear all
NCT00911716 2019-08-01

TC Avastin. ICORG 08-10, V6

Cancer Trials Ireland

Phase NA Completed
106 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00343863 2017-07-11

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

University of Washington

Phase NA Completed
41 enrolled 12 charts
Breast

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male

NCT00436709 2014-01-06

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

National Cancer Institute (NCI)

Phase NA Unknown
75 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡